LN

Lekh Narayan Karna

Director Director DIN 09826083
DIN 09826083 First appointment Dec 2022 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Dec 2022
Shareholding value Locked Premium profile

About Lekh Narayan Karna

Data last updated:

Lekh Narayan Karna has 3 years in corporate governance. Formerly with 1 company, such as Impact Therapeutics Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09826083
Primary Designation Director
First Appointment 15 Dec 2022
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Impact Therapeutics Limited U51909MH2010PLC211564
Director15 Dec 20222010Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Impact Therapeutics Limited
Premium access

Shareholding and investment profile for Lekh Narayan Karna

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lekh Narayan Karna

Lekh Narayan Karna has 3 years in corporate governance. Formerly with 1 company, such as Impact Therapeutics Limited. Engaged in General Business. Contributes to corporate operations.

Lekh Narayan Karna is associated with 0 companies as a director.

Lekh Narayan Karna has expertise in General Business.

Lekh Narayan Karna has 3 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available